Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05599425 · ClinicalTrials.gov registry record · NA

Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease

A NA study of Alzheimer Disease, sponsored by Rhode Island Hospital.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05599425 is a NA study of Alzheimer Disease that is actively recruiting participants, run by Rhode Island Hospital. The registered enrollment target is 40 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05599425, a NA study of Alzheimer Disease, is actively recruiting participants, sponsored by Rhode Island Hospital.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Modifying health behaviors like physical activity level, diet, stress, and mental activity level can lower risk for Alzheimer's disease, but many middle-aged and older adults find it difficult to sustain health behavior changes over the long term. This project will develop a new intervention that educates people about Alzheimer's disease risk factors and helps them understand how their personal health beliefs may prevent them from making long-lasting lifestyle changes. The goal is to help people sustain health behavior changes to prevent or delay the onset of Alzheimer's disease and related dementias.

Conditions Studied

Interventions

  • BEHAVIORAL Enhanced Healthy Living Education
  • BEHAVIORAL Basic Healthy Living Education

Study Locations (1)

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-03-01
Est. Completion 2025-02-01
Phase NA

Sponsor

Rhode Island Hospital

130 total trials

What the Registry Record Tells You About NCT05599425

The ClinicalTrials.gov registry entry for NCT05599425 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Healthy Living Education is the first listed.

NCT05599425 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT05599425 about?

NCT05599425 is a clinical study titled "Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease". Modifying health behaviors like physical activity level, diet, stress, and mental activity level can lower risk for Alzheimer's disease, but many middle-aged and older adults find it difficult to sustain health behavior changes over the long term. This project will develop a new intervention that ed...

What is the current status of trial NCT05599425?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-03-01. Estimated completion is 2025-02-01.

What conditions does trial NCT05599425 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT05599425?

The interventions under investigation include: Enhanced Healthy Living Education (BEHAVIORAL), Basic Healthy Living Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT05599425?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05599425 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.